Vivani Medical, Inc. - Understand $vani stock

$VANI Market Cap: $78.78 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

-$23.46M

TTM

Current Assets

$21.40M

Q3 2024

Current Liabilities

$6.270M

Q3 2024

Current Ratio

341.29%

Q3 2024

Total Assets

$42.90M

Q3 2024

Total Liabilities

$24.56M

Q3 2024

Book Value

$18.33M

Q3 2024

Cash

$19.65M

Q3 2024

P/E

-3.358

Nov 29, 2024 EST

Free Cash Flow

-$19.46M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	$0.00	$0.00			$3.400M	$6.900M	$7.960M	$3.985M	$8.950M	$3.400M	$1.560M	$1.370M
YoY Change					-50.72%	-13.32%	99.75%	-55.47%	163.24%	117.95%	13.87%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Revenue	$0.00	$0.00			$3.400M	$6.900M	$7.960M	$3.985M	$8.950M	$3.400M	$1.560M	$1.370M
Cost Of Revenue			-$130.0K	$500.0K	$2.152M	$4.888M	$5.117M	$10.08M	$5.290M	$3.560M	$5.630M	$4.400M
Gross Profit			$130.0K	$500.0K	$1.227M	$2.008M	$2.847M	-$6.091M	$3.660M	-$160.0K	-$4.060M	-$3.030M
Gross Profit Margin					36.09%	29.1%	35.77%	-152.85%	40.89%	-4.71%	-260.26%	-221.17%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Selling, General & Admin	$9.997M	$7.070M	$6.693M	$8.330M	$18.68M	$22.03M	$20.50M	$19.07M	$20.67M	$16.03M	$10.68M	$9.950M
YoY Change	41.4%	5.63%	-19.65%	-55.41%	-15.2%	7.45%	7.51%	-7.75%	28.95%	50.09%	7.34%
% of Gross Profit			5148.46%	1666.0%	1522.41%	1097.01%	720.09%		564.75%
Research & Development	$16.97M	$14.17M	$2.370M	$4.840M	$13.14M	$10.01M	$7.893M	$5.347M	$3.040M	$5.040M	$3.250M	$3.050M
YoY Change	19.75%	497.89%	-51.03%	-63.17%	31.36%	26.76%	47.62%	75.89%	-39.68%	55.08%	6.56%
% of Gross Profit			1823.08%	968.0%	1071.15%	498.26%	277.24%		83.06%
Depreciation & Amortization	$357.0K	$380.0K	$70.00K	$164.0K	$397.0K	$435.0K	$457.0K	$432.0K	$340.0K	$280.0K	$320.0K	$320.0K
YoY Change	-6.05%	442.86%	-57.32%	-58.69%	-8.74%	-4.81%	5.79%	27.06%	21.43%	-12.5%	0.0%
% of Gross Profit			53.85%	32.8%	32.36%	21.66%	16.05%		9.29%
Operating Expenses	$26.97M	$21.24M	$9.063M	$15.40M	$35.18M	$37.19M	$31.46M	$27.12M	$23.71M	$21.08M	$13.93M	$12.99M
YoY Change	26.95%	134.36%	-41.13%	-56.24%	-5.4%	18.22%	15.99%	14.38%	12.48%	51.33%	7.24%
Operating Profit	-$26.97M	-$21.24M	-$8.933M	-$14.90M	-$33.95M	-$35.18M	-$28.61M	-$33.21M	-$20.05M	-$21.24M	-$17.99M	-$16.02M
YoY Change	26.95%	137.78%	-40.03%	-56.13%	-3.48%	22.97%	-13.85%	65.64%	-5.6%	18.07%	12.3%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Interest Expense			$12.00K	$20.00K	$360.0K	$90.00K	$90.00K	$30.00K	$0.00	-$7.020M	-$5.010M	-$260.0K
YoY Change			-40.0%	-94.44%	300.0%	0.0%	200.0%		-100.0%	40.12%	1826.92%
% of Operating Profit
Other Income/Expense, Net	$1.313M	$480.0K					$0.00	$0.00	$30.00K	$10.00K	$30.00K	$0.00
YoY Change	173.54%							-100.0%	200.0%	-66.67%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Pretax Income	-$25.65M	-$13.89M	-$8.921M	-$14.88M	-$33.59M	-$35.09M	-$28.52M	-$33.18M	-$20.02M	-$35.20M	-$22.97M	-$16.28M
YoY Change	84.68%	55.7%	-40.05%	-55.7%	-4.27%	23.04%	-14.04%	65.73%	-43.13%	53.24%	41.09%
Income Tax					$0.00	$0.00	$0.00				$0.00	$0.00
% Of Pretax Income
Net Earnings	-$25.65M	-$13.89M	-$8.921M	-$14.88M	-$33.59M	-$35.09M	-$28.52M	-$33.18M	-$20.02M	-$35.20M	-$22.97M	-$16.28M
YoY Change	84.68%	55.7%	-40.05%	-55.7%	-4.28%	23.07%	-14.05%	65.73%	-43.13%	53.24%	41.09%
Net Earnings / Revenue					-988.0%	-508.61%	-358.24%	-832.6%	-223.69%	-1035.29%	-1472.44%	-1188.32%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.50	-$0.36	-$815.5K	-$723.0K	-$2.283M	-$4.228M	-$4.213M	-$6.717M	-$4.499M	-$11.25M	-$5.305M	-$3.760M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Cash & Short-Term Investments	$20.65M	$45.08M	$69.59M	$3.180M	$11.33M	$4.470M	$7.840M	$10.88M	$15.96M	$34.62M	$8.670M	$4.450M
YoY Change	-54.18%	-35.22%	2088.46%	-71.93%	153.47%	-42.98%	-27.94%	-31.83%	-53.9%	299.31%	94.83%
Cash & Equivalents	$20.65M	$45.08M	$69.59M	$3.180M	$11.33M	$4.470M	$7.240M	$10.34M	$15.72M	$34.00M	$8.610M	$4.310M
Short-Term Investments
Other Short-Term Assets	$2.408M	$2.450M	$914.0K	$1.090M	$300.0K	$1.400M	$800.0K	$720.0K	$1.090M	$930.0K	$300.0K	$430.0K
YoY Change	-1.71%	168.05%	-16.15%	263.33%	-78.57%	75.0%	11.11%	-33.94%	17.2%	210.0%	-30.23%
Inventory				$0.00	$1.030M	$3.250M	$2.700M	$3.420M	$8.210M	$5.720M	$2.350M	$1.790M
Prepaid Expenses
Receivables					$460.0K	$500.0K	$1.830M	$270.0K	$1.500M	$710.0K	$470.0K	$320.0K
Other Receivables					$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$50.00K
Total Short-Term Assets	$23.06M	$47.53M	$70.51M	$4.270M	$13.11M	$9.620M	$13.17M	$15.28M	$26.76M	$41.98M	$11.79M	$7.040M
YoY Change	-51.48%	-32.59%	1551.22%	-67.43%	36.28%	-26.96%	-13.81%	-42.9%	-36.26%	256.06%	67.47%
Property, Plant & Equipment	$21.35M	$1.960M	$345.0K	$170.0K	$3.460M	$1.030M	$1.300M	$1.490M	$1.430M	$1.000M	$720.0K	$790.0K
YoY Change	989.03%	468.12%	102.94%	-95.09%	235.92%	-20.77%	-12.75%	4.2%	43.0%	38.89%	-8.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$52.00K	$280.0K	$27.00K	$20.00K	$30.00K	$40.00K	$30.00K	$40.00K	$50.00K	$90.00K	$160.0K	$160.0K
YoY Change	-81.43%	937.04%	35.0%	-33.33%	-25.0%	33.33%	-25.0%	-20.0%	-44.44%	-43.75%	0.0%
Other Assets	$1.338M	$1.370M
YoY Change	-2.34%
Total Long-Term Assets	$22.74M	$3.600M	$372.0K	$190.0K	$3.490M	$1.060M	$1.330M	$1.530M	$1.490M	$1.090M	$880.0K	$950.0K
YoY Change	531.53%	867.74%	95.79%	-94.56%	229.25%	-20.3%	-13.07%	2.68%	36.7%	23.86%	-7.37%
Total Assets	$45.80M	$51.13M	$70.88M	$4.460M	$16.60M	$10.68M	$14.50M	$16.81M	$28.25M	$43.07M	$12.67M	$7.990M
YoY Change
Accounts Payable	$542.0K	$1.180M	$519.0K	$490.0K	$1.090M	$1.310M	$750.0K	$1.160M	$710.0K	$510.0K	$310.0K	$730.0K
YoY Change	-54.07%	127.36%	5.92%	-55.05%	-16.79%	74.67%	-35.34%	63.38%	39.22%	64.52%	-57.53%
Accrued Expenses	$5.181M	$5.650M	$1.943M	$2.110M	$5.530M	$6.130M	$5.820M	$4.320M	$4.750M	$3.260M	$2.300M	$1.810M
YoY Change	-8.3%	190.79%	-7.91%	-61.84%	-9.79%	5.33%	34.72%	-9.05%	45.71%	41.74%	27.07%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00	$2.200M							$0.00	$50.00K
YoY Change			-100.0%								-100.0%
Total Short-Term Liabilities	$5.723M	$6.820M	$2.462M	$5.130M	$6.960M	$7.600M	$6.620M	$5.660M	$7.980M	$8.450M	$2.680M	$2.760M
YoY Change	-16.09%	177.01%	-52.01%	-26.29%	-8.42%	14.8%	16.96%	-29.07%	-5.56%	215.3%	-2.9%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$19.21M	$8.270M
YoY Change										-100.0%	132.29%
Other Long-Term Liabilities	$19.31M	$0.00	$52.00K	$0.00	$2.370M
YoY Change		-100.0%		-100.0%
Total Long-Term Liabilities	$19.31M	$0.00	$52.00K	$0.00	$2.370M	$0.00	$0.00	$0.00	$0.00	$0.00	$19.21M	$8.270M
YoY Change		-100.0%		-100.0%						-100.0%	132.29%
Total Liabilities	$25.04M	$6.820M	$2.514M	$5.130M	$9.320M	$7.600M	$6.620M	$5.660M	$7.980M	$8.450M	$21.89M	$11.04M
YoY Change	267.1%	171.28%	-50.99%	-44.96%	22.63%	14.8%	16.96%	-29.07%	-5.56%	-61.4%	98.28%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $78.782 Million

About Vivani Medical, Inc.

Vivani Medical, Inc. develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. The company is headquartered in Alameda, California and currently employs 44 full-time employees. The company went IPO on 2014-12-05. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115, utilizes a miniature, six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of chronic weight management in obese or overweight individuals. Its pipeline also includes the NPM-139 (semaglutide) implant which is also under development for chronic weight management in obese and overweight individuals. NPM-119 refers to its Type II diabetes development program. OKV-119 is an exenatide implant that is under development for metabolic diseases in cats, including for the treatment of obesity and diabetes. Its segments include Biopharm Division and Neurostimulation Division.

Industry: Electromedical & Electrotherapeutic Apparatus Peers: ABBOTT LABORATORIES Conformis Inc Microbot Medical Inc. Sonendo, Inc. electroCore, Inc. INVACARE HOLDINGS Corp Nemaura Medical Inc. PRECISION OPTICS CORPORATION, INC. SANUWAVE Health, Inc.